First Time Loading...
H

Humasis Co Ltd
KOSDAQ:205470

Watchlist Manager
Humasis Co Ltd
KOSDAQ:205470
Watchlist
Price: 1 768 KRW 0.06% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

Humasis Co., Ltd. engages in developing rapid test kits and point-of-care testing instruments. [ Read More ]

The intrinsic value of one Humasis Co Ltd stock under the Base Case scenario is 1 907.94 KRW. Compared to the current market price of 1 768 KRW, Humasis Co Ltd is Undervalued by 7%.

Key Points:
Intrinsic Value
Base Case
1 907.94 KRW
Undervaluation 7%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation Backtest
Humasis Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Humasis Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Humasis Co Ltd

Provide an overview of the primary business activities
of Humasis Co Ltd.

What unique competitive advantages
does Humasis Co Ltd hold over its rivals?

What risks and challenges
does Humasis Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Humasis Co Ltd.

Provide P/S
for Humasis Co Ltd.

Provide P/E
for Humasis Co Ltd.

Provide P/OCF
for Humasis Co Ltd.

Provide P/FCFE
for Humasis Co Ltd.

Provide P/B
for Humasis Co Ltd.

Provide EV/S
for Humasis Co Ltd.

Provide EV/GP
for Humasis Co Ltd.

Provide EV/EBITDA
for Humasis Co Ltd.

Provide EV/EBIT
for Humasis Co Ltd.

Provide EV/OCF
for Humasis Co Ltd.

Provide EV/FCFF
for Humasis Co Ltd.

Provide EV/IC
for Humasis Co Ltd.

Compare the intrinsic valuations
of Humasis Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Humasis Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Humasis Co Ltd compared to its peers.

Compare the P/E ratios
of Humasis Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Humasis Co Ltd with its peers.

Analyze the financial leverage
of Humasis Co Ltd compared to its main competitors.

Show all profitability ratios
for Humasis Co Ltd.

Provide ROE
for Humasis Co Ltd.

Provide ROA
for Humasis Co Ltd.

Provide ROIC
for Humasis Co Ltd.

Provide ROCE
for Humasis Co Ltd.

Provide Gross Margin
for Humasis Co Ltd.

Provide Operating Margin
for Humasis Co Ltd.

Provide Net Margin
for Humasis Co Ltd.

Provide FCF Margin
for Humasis Co Ltd.

Show all solvency ratios
for Humasis Co Ltd.

Provide D/E Ratio
for Humasis Co Ltd.

Provide D/A Ratio
for Humasis Co Ltd.

Provide Interest Coverage Ratio
for Humasis Co Ltd.

Provide Altman Z-Score Ratio
for Humasis Co Ltd.

Provide Quick Ratio
for Humasis Co Ltd.

Provide Current Ratio
for Humasis Co Ltd.

Provide Cash Ratio
for Humasis Co Ltd.

What is the historical Revenue growth
over the last 5 years for Humasis Co Ltd?

What is the historical Net Income growth
over the last 5 years for Humasis Co Ltd?

What is the current Free Cash Flow
of Humasis Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Humasis Co Ltd.

Financials

Balance Sheet Decomposition
Humasis Co Ltd

Current Assets 277.8B
Cash & Short-Term Investments 243B
Receivables 23.9B
Other Current Assets 10.9B
Non-Current Assets 69.5B
Long-Term Investments 11.4B
PP&E 57.6B
Other Non-Current Assets 507.6m
Current Liabilities 59.8B
Accounts Payable 456.3m
Accrued Liabilities 7.7B
Other Current Liabilities 51.6B
Non-Current Liabilities 218.1m
Long-Term Debt 171.8m
Other Non-Current Liabilities 46.3m
Efficiency

Earnings Waterfall
Humasis Co Ltd

Revenue
13.8B KRW
Cost of Revenue
-50.8B KRW
Gross Profit
-36.9B KRW
Operating Expenses
-15.4B KRW
Operating Income
-52.4B KRW
Other Expenses
-3.1B KRW
Net Income
-55.4B KRW

Free Cash Flow Analysis
Humasis Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

Humasis Co Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Negative 1-Year Revenue Growth
Declining ROE
34/100
Profitability
Score

Humasis Co Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Humasis Co Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
67/100
Solvency
Score

Humasis Co Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Humasis Co Ltd

There are no price targets for Humasis Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Humasis Co Ltd

1M 1M
-14%
6M 6M
-20%
1Y 1Y
-45%
3Y 3Y
-69%
5Y 5Y
+300%
10Y 10Y
+260%
Annual Price Range
1 768
52w Low
1 632
52w High
3 235
Price Metrics
Average Annual Return 146.13%
Standard Deviation of Annual Returns 266.81%
Max Drawdown -81%
Shares Statistics
Market Capitalization 224.9B KRW
Shares Outstanding 127 212 932
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Humasis Co Ltd

Country

Korea

Industry

Health Care

Market Cap

224.9B KRW

Dividend Yield

0%

Description

Humasis Co., Ltd. engages in developing rapid test kits and point-of-care testing instruments. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2014-12-01. The firm is engaged in the manufacture and sale of immunoquantitative analysis devices, myocardial infarction test equipment, infectious disease detection devices, hormone test devices, cancer marker test devices and other products. In addition, the Company is engaged in the research and development of biomaterials and other products. The firm sells its products within domestic market and to overseas markets. The firm was established in 2000 and is located in Gunpo-si, Gyeonggi-do, South Korea.

Contact

GYEONGGI-DO
Anyang
504, Shinwon Vision Tower, 88, Jeonpa-ro, Dongan-gu
+823180856200
https://www.humasis.com/

IPO

2014-12-01

Employees

298

Officers

Chief Executive Officer
Sung-gon Kim

See Also

Discover More
What is the Intrinsic Value of one Humasis Co Ltd stock?

The intrinsic value of one Humasis Co Ltd stock under the Base Case scenario is 1 907.94 KRW.

Is Humasis Co Ltd stock undervalued or overvalued?

Compared to the current market price of 1 768 KRW, Humasis Co Ltd is Undervalued by 7%.